{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:45:37Z","timestamp":1789587937516,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:00:00Z","timestamp":1559088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thyroid cancer is the most common endocrine malignancy. Anaplastic thyroid cancer is one of the most aggressive thyroid tumors. It is known that activation of oncogenes and\/or inactivation of tumor suppressor genes in tumor cells promotes tumorigenesis. The microenvironment of the tumor also plays a key role on cancer development and progression in a variety of tumors. However, the mechanisms by which tumor-stroma crosstalk in thyroid cancer remains poorly characterized. In this study we aimed to understand how interactions between fibroblasts and anaplastic thyroid cancer cells contribute to thyroid carcinogenesis. We first characterized the phenotypic changes of human fibroblasts <jats:italic>in vitro<\/jats:italic> through co-cultures by using transwells as well as by using anaplastic thyroid cancer cells-derived conditioned media. We found that fibroblasts acquired an activated phenotype or also known as cancer-associated fibroblast phenotype after being in contact with soluble factors secreted from anaplastic thyroid cancer cells, compared to the fibroblasts in mono-cultures. All the changes were partly mediated through Src\/Akt activation. Treatment with the antioxidant N-acetyl-cysteine reversed in part the metabolic phenotype of activated fibroblasts. Remarkably, conditioned media obtained from these activated fibroblasts promoted cell proliferation and invasion of follicular thyroid cancer cell line, FTC-133 cells. Thus, a reciprocal and dynamic interaction exists between tumor and stromal cells, which results in the promotion of thyroid tumorigenesis. The present studies have advanced the understanding of the molecular basis of tumor-stroma communications, enabling identification and targeting of tumor-supportive mechanisms for novel treatment modalities.<\/jats:p>","DOI":"10.1038\/s41598-019-44361-6","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T10:02:24Z","timestamp":1559124144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Laura","family":"Fozzatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanina Alejandra","family":"Alamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucila","family":"Giusiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Volpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthia Carolina","family":"Stempin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheue-yann","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Gabriela","family":"Pellizas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,29]]},"reference":[{"key":"44361_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","volume":"25","author":"LA Torre","year":"2016","unstructured":"Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global Cancer Incidence and Mortality Rates and Trends\u2013An Update. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 25, 16\u201327 (2016).","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"44361_CR2","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA: a cancer journal for clinicians (2018).","DOI":"10.3322\/caac.21442"},{"key":"44361_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/1097-0142(19900715)66:2<321::AID-CNCR2820660221>3.0.CO;2-A","volume":"66","author":"YS Venkatesh","year":"1990","unstructured":"Venkatesh, Y. S. et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66, 321\u2013330 (1990).","journal-title":"Cancer"},{"key":"44361_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro, E. et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nature reviews. Endocrinology 13, 644\u2013660 (2017).","journal-title":"Nature reviews. Endocrinology"},{"key":"44361_CR5","doi-asserted-by":"crossref","unstructured":"Tiedje, V. et al. Anaplastic thyroid carcinoma: review of treatment protocols. Endocrine-related cancer (2018).","DOI":"10.1530\/ERC-17-0435"},{"key":"44361_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer cell 21, 309\u2013322 (2012).","journal-title":"Cancer cell"},{"key":"44361_CR7","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri, R. The biology and function of fibroblasts in cancer. Nature reviews. Cancer 16, 582\u2013598 (2016).","journal-title":"Nature reviews. Cancer"},{"key":"44361_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1084\/jem.20140692","volume":"211","author":"D Ohlund","year":"2014","unstructured":"Ohlund, D., Elyada, E. & Tuveson, D. Fibroblast heterogeneity in the cancer wound. The Journal of experimental medicine 211, 1503\u20131523 (2014).","journal-title":"The Journal of experimental medicine"},{"key":"44361_CR9","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup, M., Novitskiy, S. & Moses, H. L. The roles of TGFbeta in the tumour microenvironment. Nature reviews. Cancer 13, 788\u2013799 (2013).","journal-title":"Nature reviews. Cancer"},{"key":"44361_CR10","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1158\/0008-5472.CAN-10-0785","volume":"70","author":"E Giannoni","year":"2010","unstructured":"Giannoni, E. et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer research 70, 6945\u20136956 (2010).","journal-title":"Cancer research"},{"key":"44361_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","volume":"91","author":"C Kahlert","year":"2013","unstructured":"Kahlert, C. & Kalluri, R. Exosomes in tumor microenvironment influence cancer progression and metastasis. Journal of molecular medicine 91, 431\u2013437 (2013).","journal-title":"Journal of molecular medicine"},{"key":"44361_CR12","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1016\/j.yexcr.2010.04.032","volume":"316","author":"K Rasanen","year":"2010","unstructured":"Rasanen, K. & Vaheri, A. Activation of fibroblasts in cancer stroma. Experimental cell research 316, 2713\u20132722 (2010).","journal-title":"Experimental cell research"},{"key":"44361_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature reviews. Cancer 6, 392\u2013401 (2006).","journal-title":"Nature reviews. Cancer"},{"key":"44361_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrc1477","volume":"4","author":"MM Mueller","year":"2004","unstructured":"Mueller, M. M. & Fusenig, N. E. Friends or foes - bipolar effects of the tumour stroma in cancer. Nature reviews. Cancer 4, 839\u2013849 (2004).","journal-title":"Nature reviews. Cancer"},{"key":"44361_CR15","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail, D. F. & Joyce, J. A. Microenvironmental regulation of tumor progression and metastasis. Nature medicine 19, 1423\u20131437 (2013).","journal-title":"Nature medicine"},{"key":"44361_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","volume":"25","author":"A Costa","year":"2014","unstructured":"Costa, A., Scholer-Dahirel, A. & Mechta-Grigoriou, F. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Seminars in cancer biology 25, 23\u201332 (2014).","journal-title":"Seminars in cancer biology"},{"key":"44361_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn, U. E., Peiris-Pages, M., Pestell, R. G., Sotgia, F. & Lisanti, M. P. Cancer metabolism: a therapeutic perspective. Nature reviews. Clinical oncology 14, 11\u201331 (2017).","journal-title":"Nature reviews. Clinical oncology"},{"key":"44361_CR18","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari, N., Dwarakanath, B. S., Das, A. & Bhatt, A. N. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 37, 11553\u201311572 (2016).","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"44361_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/105072503321582042","volume":"13","author":"J Kurebayashi","year":"2003","unstructured":"Kurebayashi, J. et al. Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2. Thyroid: official journal of the American Thyroid Association 13, 249\u2013258 (2003).","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"key":"44361_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature reviews. Cancer 11, 85\u201395 (2011).","journal-title":"Nature reviews. Cancer"},{"key":"44361_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1677\/ERC-08-0251","volume":"17","author":"N Burrows","year":"2010","unstructured":"Burrows, N. et al. Expression of hypoxia-inducible factor 1 alpha in thyroid carcinomas. Endocrine-related cancer 17, 61\u201372 (2010).","journal-title":"Endocrine-related cancer"},{"key":"44361_CR22","doi-asserted-by":"publisher","first-page":"25450311","DOI":"10.1155\/2017\/2545031","volume":"2017","author":"D Ciavardelli","year":"2017","unstructured":"Ciavardelli, D., Bellomo, M., Consalvo, A., Crescimanno, C. & Vella, V. Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets. BioMed research international 2017, 25450311 (2017).","journal-title":"BioMed research international"},{"key":"44361_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tibs.2016.01.002","volume":"41","author":"KA Olson","year":"2016","unstructured":"Olson, K. A., Schell, J. C. & Rutter, J. Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies. Trends in biochemical sciences 41, 219\u2013230 (2016).","journal-title":"Trends in biochemical sciences"},{"key":"44361_CR24","doi-asserted-by":"publisher","first-page":"101042831769592","DOI":"10.1177\/1010428317695922","volume":"39","author":"JH Nahm","year":"2017","unstructured":"Nahm, J. H., Kim, H. M. & Koo, J. S. Glycolysis-related protein expression in thyroid cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 39, 1010428317695922 (2017).","journal-title":"Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"key":"44361_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/jpet.114.216044","volume":"351","author":"M Hu","year":"2014","unstructured":"Hu, M. et al. Therapeutic targeting of SRC kinase in myofibroblast differentiation and pulmonary fibrosis. The Journal of pharmacology and experimental therapeutics 351, 87\u201395 (2014).","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"44361_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB Signaling: Navigating the Network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"44361_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"JW Lee","year":"2004","unstructured":"Lee, J. W., Bae, S. H., Jeong, J. W., Kim, S. H. & Kim, K. W. Hypoxia-inducible factor (HIF-1) alpha: its protein stability and biological functions. Experimental & molecular medicine 36, 1\u201312 (2004).","journal-title":"Experimental & molecular medicine"},{"key":"44361_CR28","doi-asserted-by":"publisher","first-page":"e54302","DOI":"10.1371\/journal.pone.0054302","volume":"8","author":"M Ryder","year":"2013","unstructured":"Ryder, M. et al. Genetic and pharmacological targeting of CSF-1\/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PloS one 8, e54302 (2013).","journal-title":"PloS one"},{"key":"44361_CR29","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-15-2351","volume":"76","author":"LA Jolly","year":"2016","unstructured":"Jolly, L. A. et al. Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. Cancer research 76, 1804\u20131813 (2016).","journal-title":"Cancer research"},{"key":"44361_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/thy.2013.0054","volume":"24","author":"WG Kim","year":"2014","unstructured":"Kim, W. G., Zhao, L., Kim, D. W., Willingham, M. C. & Cheng, S. Y. Inhibition of tumorigenesis by the thyroid hormone receptor beta in xenograft models. Thyroid: official journal of the American Thyroid Association 24, 260\u2013269 (2014).","journal-title":"Thyroid: official journal of the American Thyroid Association"},{"key":"44361_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1677\/joe.1.06967","volume":"192","author":"L Fozzatti","year":"2007","unstructured":"Fozzatti, L. et al. Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells. The Journal of endocrinology 192, 627\u2013637 (2007).","journal-title":"The Journal of endocrinology"},{"key":"44361_CR32","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.1073\/pnas.1222334110","volume":"110","author":"L Fozzatti","year":"2013","unstructured":"Fozzatti, L. et al. Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor alpha. Proceedings of the National Academy of Sciences of the United States of America 110, 7850\u20137855 (2013).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"44361_CR33","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1210\/jc.2016-3771","volume":"102","author":"K Enomoto","year":"2017","unstructured":"Enomoto, K. et al. Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer. The Journal of clinical endocrinology and metabolism 102, 2268\u20132280 (2017).","journal-title":"The Journal of clinical endocrinology and metabolism"}],"updated-by":[{"DOI":"10.1038\/s41598-019-54273-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44361-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:07:45Z","timestamp":1671271665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,29]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44361"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44361-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,29]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8028"}}